Astaria Global
Astaria Global is dedicated to inspiring animal science through innovative regenerative and orthobiologic therapies, particularly for equine health. Their mission is to improve the quality of life, performance, and well-being of horses by providing scientifically advanced, drug-free treatment options that modulate cartilage degeneration and reduce inflammation. They focus on developing and providing products like Alpha2EQ, which utilizes patented filtration technology to deliver anti-inflammatory support directly to affected areas, promoting healing and slowing disease progression.
Industries
Nr. of Employees
small (1-50)
Astaria Global
Houston, Texas, United States, North America
Products
Autologous plasma processing kit — multi-dose (approx. 30 mL workflow)
A kit to collect autologous blood, separate plasma by centrifugation, perform a secondary filtration/concentration step and yield a multi-dose alpha-2-macroglobulin–enriched injectate; designed for on-site use with supporting instruction materials.
Autologous plasma processing kit — single/limited-dose (approx. 15 mL workflow)
A smaller-volume kit and procedure for collecting and processing autologous blood into an alpha-2-macroglobulin–enriched injectate using a single-syringe/one-conical-tube workflow.
Technical bulletins and white papers
Downloadable PDFs and technical documents summarizing mechanism of action, pilot data, safety studies and comparative analyses relevant to autologous alpha-2-macroglobulin therapeutics.
Autologous plasma processing kit — multi-dose (approx. 30 mL workflow)
A kit to collect autologous blood, separate plasma by centrifugation, perform a secondary filtration/concentration step and yield a multi-dose alpha-2-macroglobulin–enriched injectate; designed for on-site use with supporting instruction materials.
Autologous plasma processing kit — single/limited-dose (approx. 15 mL workflow)
A smaller-volume kit and procedure for collecting and processing autologous blood into an alpha-2-macroglobulin–enriched injectate using a single-syringe/one-conical-tube workflow.
Technical bulletins and white papers
Downloadable PDFs and technical documents summarizing mechanism of action, pilot data, safety studies and comparative analyses relevant to autologous alpha-2-macroglobulin therapeutics.
Services
Veterinary training and protocol support
Provision of processing protocols, QuickStart guides, training videos, and phone/email technical support to veterinarians implementing on-site autologous plasma processing.
Nebulizer device distribution and practitioner pricing
Provision and practitioner pricing for nebulizer delivery devices to support airway administration of processed autologous biologic products.
Research resource distribution and case-study access
Distribution of scientific articles, technical bulletins, pilot-study reports and case studies relevant to alpha-2-macroglobulin therapeutics for clinicians and researchers.
Veterinary training and protocol support
Provision of processing protocols, QuickStart guides, training videos, and phone/email technical support to veterinarians implementing on-site autologous plasma processing.
Nebulizer device distribution and practitioner pricing
Provision and practitioner pricing for nebulizer delivery devices to support airway administration of processed autologous biologic products.
Research resource distribution and case-study access
Distribution of scientific articles, technical bulletins, pilot-study reports and case studies relevant to alpha-2-macroglobulin therapeutics for clinicians and researchers.
Expertise Areas
- Orthobiologic therapy development
- Autologous plasma processing at point-of-care
- Veterinary clinical protocol development for equine musculoskeletal disease
- Airway nebulized biologic administration
Key Technologies
- Centrifugation-based plasma separation
- Filtration-based protein enrichment
- Autologous alpha-2-macroglobulin enrichment
- On-site kit-based biologics processing